DD - DuPont de Nemours, Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
Wilmington,
United States
Type: Equity
DD price evolution
DD
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2803 | $1747 | $4996 | $3629 |
| Short term investments | $1319 | |||
| Net receivables | $2370 | $2399 | $2315 | $2438 |
| Inventory | $2147 | $2279 | $2341 | $2443 |
| Total current assets | $7514 | $7935 | $11127 | $11200 |
| Long term investments | $1071 | $751 | $757 | $744 |
| Property, plant & equipment | $5884 | $5756 | $5701 | $5738 |
| Goodwill & intangible assets | $22534 | $23289 | $21833 | $22069 |
| Total noncurrent assets | $31038 | $31198 | $29670 | $30008 |
| Total investments | $1071 | $751 | $757 | $2063 |
| Total assets | $38552 | $39133 | $40797 | $41208 |
| Current liabilities | ||||
| Accounts payable | $1675 | $1685 | $1768 | $1921 |
| Deferred revenue | ||||
| Short long term debt | $475 | $300 | $300 | |
| Total current liabilities | $3098 | $3688 | $3739 | $3406 |
| Long term debt | $7800 | $7740 | $7775 | $7807 |
| Total noncurrent liabilities | $10729 | $10818 | $10505 | $10641 |
| Total debt | $7800 | $8215 | $8075 | $8107 |
| Total liabilities | $14273 | $14506 | $14244 | $14047 |
| Shareholders' equity | ||||
| Retained earnings | -$22874 | -$22854 | -$20938 | -$20807 |
| Other shareholder equity | -$910 | -$1148 | -$890 | -$717 |
| Total shareholder equity | $24279 | $24192 | $26123 | $26737 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2803 | $3765 | $2064 | $8750 |
| Short term investments | $1302 | |||
| Net receivables | $2370 | $2518 | $2711 | $3551 |
| Inventory | $2147 | $2329 | $2862 | $3726 |
| Total current assets | $7514 | $11270 | $8065 | $10877 |
| Long term investments | $1071 | $733 | $981 | $1083 |
| Property, plant & equipment | $5884 | $6157 | $6966 | $9985 |
| Goodwill & intangible assets | $22534 | $22158 | $28020 | $41388 |
| Total noncurrent assets | $31038 | $30085 | $37642 | $60027 |
| Total investments | $1071 | $2035 | $981 | $1083 |
| Total assets | $38552 | $41355 | $45707 | $70904 |
| Current liabilities | ||||
| Accounts payable | $1675 | $2103 | $2612 | $2964 |
| Deferred revenue | ||||
| Short long term debt | $300 | $150 | $5 | |
| Total current liabilities | $3098 | $3733 | $4262 | $4699 |
| Long term debt | $7800 | $7774 | $10632 | $21806 |
| Total noncurrent liabilities | $10729 | $10605 | $14395 | $27135 |
| Total debt | $7800 | $8074 | $10782 | $21811 |
| Total liabilities | $14273 | $14786 | $18657 | $31834 |
| Shareholders' equity | ||||
| Retained earnings | -$22874 | -$21065 | -$23187 | -$11586 |
| Other shareholder equity | -$910 | -$791 | $41 | $44 |
| Total shareholder equity | $24279 | $26569 | $26433 | $38504 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2898 | $3058 | $3094 | $3018 |
| Cost of revenue | $1954 | $2030 | $1983 | |
| Gross Profit | $1030 | $1104 | $1064 | $1035 |
| Operating activities | ||||
| Research & development | $128 | $125 | $127 | |
| Selling, general & administrative | $360 | $358 | $340 | |
| Total operating expenses | $640 | $605 | $624 | $599 |
| Operating income | $499 | $440 | $436 | |
| Income from continuing operations | ||||
| EBIT | $538 | $54 | $435 | |
| Income tax expense | -$316 | $117 | $87 | $83 |
| Interest expense | -$90 | $102 | $98 | $95 |
| Net income | ||||
| Net income | -$22 | $319 | -$131 | $257 |
| Income (for common shares) | $319 | -$131 | $257 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12068 | $13017 | $16653 | $20397 |
| Cost of revenue | $8402 | $10803 | $13522 | |
| Gross Profit | $4233 | $4615 | $5850 | $6875 |
| Operating activities | ||||
| Research & development | $536 | $618 | $860 | |
| Selling, general & administrative | $1467 | $1855 | $2235 | |
| Total operating expenses | $2414 | $2750 | $3223 | $9196 |
| Operating income | $1865 | $2627 | -$2321 | |
| Income from continuing operations | ||||
| EBIT | $6747 | $7384 | -$2207 | |
| Income tax expense | -$29 | $387 | $392 | -$23 |
| Interest expense | -$345 | $492 | $525 | $767 |
| Net income | ||||
| Net income | $423 | $5868 | $6467 | -$2951 |
| Income (for common shares) | $5868 | $6467 | -$2951 | |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $319 | -$131 | $257 | |
| Operating activities | ||||
| Depreciation | $294 | $282 | $277 | |
| Business acquisitions & disposals | -$1745 | |||
| Stock-based compensation | ||||
| Total cash flows from operations | $740 | $462 | $343 | |
| Investing activities | ||||
| Capital expenditures | -$119 | -$114 | -$241 | |
| Investments | $1319 | -$17 | ||
| Total cash flows from investing | $172 | -$1911 | $1191 | -$259 |
| Financing activities | ||||
| Dividends paid | -$651 | -$165 | -$165 | -$165 |
| Sale and purchase of stock | -$1990 | $12 | ||
| Net borrowings | $175 | |||
| Total cash flows from financing | -$2989 | -$1982 | -$164 | -$213 |
| Effect of exchange rate | -$37 | -$27 | -$22 | -$7 |
| Change in cash and equivalents | -$969 | -$3249 | $1360 | -$136 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $5868 | $6467 | -$2951 | |
| Operating activities | ||||
| Depreciation | $1180 | $1458 | $3094 | |
| Business acquisitions & disposals | $10956 | -$1549 | $963 | |
| Stock-based compensation | ||||
| Total cash flows from operations | $588 | $2281 | $4095 | |
| Investing activities | ||||
| Capital expenditures | -$743 | -$891 | -$1194 | |
| Investments | -$1302 | |||
| Total cash flows from investing | $172 | $8923 | -$2401 | -$202 |
| Financing activities | ||||
| Dividends paid | -$651 | -$652 | -$630 | -$882 |
| Sale and purchase of stock | -$4287 | -$2028 | -$175 | |
| Net borrowings | -$2650 | -$3600 | $4415 | |
| Total cash flows from financing | -$2989 | -$7667 | -$6507 | $3238 |
| Effect of exchange rate | -$37 | -$148 | -$72 | $67 |
| Change in cash and equivalents | -$969 | $1696 | -$6699 | $7198 |
News
Fundamentals
| Market cap | $31.74B |
|---|---|
| Enterprise value | $36.74B |
| Shares outstanding | 430.11M |
| Revenue | $12.07B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $423.00M |
| Revenue Q/Q | -6.64% |
| Revenue Y/Y | -7.29% |
| P/E ratio | 75.04 |
|---|---|
| EV/Sales | 3.04 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.63 |
| P/B ratio | 1.26 |
| Book/Share | 58.56 |
| Cash/Share | 6.52 |
| EPS | $0.98 |
|---|---|
| ROA | 1.06% |
| ROE | 1.67% |
| Debt/Equity | 0.59 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.43 |
| Quick ratio | 1.73 |